Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
December 2, 2009
Overcoming multidrug resistance by RNA interference
Alexandra Stege, Andrea Krühn, Hermann Lage
Cancer Gene Therapy
|
September 18, 2004
Stable and complete overcoming of MDR1/P-glycoprotein-mediated multidrug resistance in human gastric carcinoma cells by RNA interference
Alexandra Stege, Axel Priebsch, Christiane Nieth, et al.
FEBS Letters
|
June 14, 2003
Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi)
Christiane Nieth, Axel Priebsch, Alexandra Stege, et al.
Biochemical and Biophysical Research Communications
|
August 1, 2006
RNA interference-triggered reversal of ABCC2-dependent cisplatin resistance in human cancer cells
Verena Materna, Alexandra Stege, Pawel Surowiak, et al.
Oncogene
|
December 9, 2003
Glypican-3 is involved in cellular protection against mitoxantrone in gastric carcinoma cells
Anke Wichert, Alexandra Stege, Yutaka Midorikawa, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 20, 2007
Complete in vivo reversal of the multidrug resistance phenotype by jet-injection of anti-MDR1 short hairpin RNA-encoding plasmid DNA
Ulrike Stein, Wolfgang Walther, Alexandra Stege, et al.
Oligonucleotides
|
September 19, 2006
Complete reversal of ABCG2-depending atypical multidrug resistance by RNA interference in human carcinoma cells
Axel Priebsch, Franziska Rompe, Holger Tönnies, et al.
Scientific Reports
|
April 29, 2025
Author Correction: A multicenter study of asymmetric and symmetric dimethylarginine as predictors of mortality risk in hospitalized COVID-19 patients
Juliane Hannemann, Anne Zink, Yoana Mileva, et al.
Scientific Reports
|
July 8, 2024
A multicenter study of asymmetric and symmetric dimethylarginine as predictors of mortality risk in hospitalized COVID-19 patients
Juliane Hannemann, Anne Zink, Yoana Mileva, et al.
Diagnostic and Prognostic Research
|
September 12, 2023
Study design for development of novel safety biomarkers of drug-induced liver injury by the translational safety biomarker pipeline (TransBioLine) consortium: a study protocol for a nested case-control study
Jane I Grove, Camilla Stephens, M Isabel Lucena, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Methods in Molecular Biology (Clifton, N.J.)
|
December 2, 2009
Overcoming multidrug resistance by RNA interference
Alexandra Stege, Andrea Krühn, Hermann Lage
Cancer Gene Therapy
|
September 18, 2004
Stable and complete overcoming of MDR1/P-glycoprotein-mediated multidrug resistance in human gastric carcinoma cells by RNA interference
Alexandra Stege, Axel Priebsch, Christiane Nieth, et al.
FEBS Letters
|
June 14, 2003
Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi)
Christiane Nieth, Axel Priebsch, Alexandra Stege, et al.
Biochemical and Biophysical Research Communications
|
August 1, 2006
RNA interference-triggered reversal of ABCC2-dependent cisplatin resistance in human cancer cells
Verena Materna, Alexandra Stege, Pawel Surowiak, et al.
Oncogene
|
December 9, 2003
Glypican-3 is involved in cellular protection against mitoxantrone in gastric carcinoma cells
Anke Wichert, Alexandra Stege, Yutaka Midorikawa, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 20, 2007
Complete in vivo reversal of the multidrug resistance phenotype by jet-injection of anti-MDR1 short hairpin RNA-encoding plasmid DNA
Ulrike Stein, Wolfgang Walther, Alexandra Stege, et al.
Oligonucleotides
|
September 19, 2006
Complete reversal of ABCG2-depending atypical multidrug resistance by RNA interference in human carcinoma cells
Axel Priebsch, Franziska Rompe, Holger Tönnies, et al.
Scientific Reports
|
April 29, 2025
Author Correction: A multicenter study of asymmetric and symmetric dimethylarginine as predictors of mortality risk in hospitalized COVID-19 patients
Juliane Hannemann, Anne Zink, Yoana Mileva, et al.
Scientific Reports
|
July 8, 2024
A multicenter study of asymmetric and symmetric dimethylarginine as predictors of mortality risk in hospitalized COVID-19 patients
Juliane Hannemann, Anne Zink, Yoana Mileva, et al.
Diagnostic and Prognostic Research
|
September 12, 2023
Study design for development of novel safety biomarkers of drug-induced liver injury by the translational safety biomarker pipeline (TransBioLine) consortium: a study protocol for a nested case-control study
Jane I Grove, Camilla Stephens, M Isabel Lucena, et al.
Page
of 2